8 Results

People

  1. Kris
    Kris
  2. Miller
    Miller
  3. Ginsberg
    Ginsberg
  4. Azzoli
    Azzoli
  5. Krug
    Krug
  6. Pao
    Pao
  7. Riely
    Riely
  8. Rizvi
    Rizvi
  9. Sirotnak
    Sirotnak
  10. Tyson
    Tyson

Groups

  1. Body Imaging Service (8)
  2. Department of Medicine (8)
  3. Radiology, Department of (8)
  4. Solid Tumor Oncology Division (8)
  5. Thoracic Oncology (8)
  6. Nursing (4)
  7. Biostatistics Service (3)
  8. Center for Pancreatic Cancer Research (3)
  9. Epidemiology and Biostatistics (3)
  10. Advanced Practice Providers (2)
  1. "Body Imaging Service"
  2. "Thoracic Oncology"
  3. "aged"
  4. "Vincent Miller"
Formats
  1. Journal Article (8)
Groups
  1. Body Imaging Service (8)
  2. Department of Medicine (8)
  3. Radiology, Department of (8)
  4. Solid Tumor Oncology Division (8)
  5. Thoracic Oncology (8)
  6. Nursing (4)

More Groups

People
  1. Mark Kris (8)
  2. Vincent Miller (8)
  3. Michelle Ginsberg (7)
  4. Christopher Azzoli (6)
  5. Lee Krug (5)
  6. Francis Sirotnak (4)

More People

Years
  1. 2011 (3)
  2. 2009 (2)
  3. 2007 (2)
  4. 2003 (1)
Publications
  1. Clinical Cancer Research (4)
  2. Journal of Thoracic Oncology (2)
  3. Archives of Pathology & Laboratory Medicine (1)
  4. Journal of Clinical Oncology (1)
Publishers
  1. American Association for Cancer Research (4)
  2. Elsevier Inc. (2)
  3. American Society of Clinical Oncology (1)
  4. College of American Pathologists (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: Safety and efficacy in a phase 1 trial
    Journal Article

    Azzoli, C. G.; Patel, J. D.; Krug, L. M.; Miller, V.; James, L.; Kris, M. G.; Ginsberg, M.; Subzwari, S.; Tyson, L.; Dunne, M.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • A phase II trial of salirasib in patients with lung adenocarcinomas with KRAS mutations
    Journal Article

    Riely, G. J.; Johnson, M. L.; Medina, C.; Rizvi, N. A.; Miller, V. A.; Kris, M. G.; Pietanza, M. C.; Azzoli, C. G.; Krug, L. M.; Pao, W.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib
    Journal Article

    Janjigian, Y. Y.; Azzoli, C. G.; Krug, L. M.; Pereira, L. K.; Rizvi, N. A.; Pietanza, M. C.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; Miller, V. A.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib
    Journal Article

    Zakowski, M. F.; Hussain, S.; Pao, W.; Ladanyi, M.; Ginsberg, M. S.; Heelan, R.; Miller, V. A.; Rusch, V. W.; Kris, M. G.
    Archives of Pathology & Laboratory Medicine (2009)

    Fulltext@MSK | Save
  • Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer
    Journal Article

    Riely, G. J.; Rizvi, N. A.; Kris, M. G.; Milton, D. T.; Solit, D. B.; Rosen, N.; Senturk, E.; Azzoli, C. G.; Brahmer, J. R.; Sirotnak, F. M.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus
    Journal Article

    Riely, G. J.; Kris, M. G.; Zhao, B.; Akhurst, T.; Milton, D. T.; Moore, E.; Tyson, L.; Pao, W.; Rizvi, N. A.; Schwartz, L. H.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors
    Journal Article

    Azzoli, C. G.; Krug, L. M.; Gomez, J.; Miller, V. A.; Kris, M. G.; Ginsberg, M. S.; Henry, R.; Jones, J.; Tyson, L.; Dunne, M.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • 10-Propargyl-10-deazaaminopterin: An antifolate with activity in patients with previously treated non-small cell lung cancer
    Journal Article

    Krug, L. M.; Azzoli, C. G.; Kris, M. G.; Miller, V. A.; Khokhar, N. Z.; Tong, W.; Ginsberg, M. S.; Venkatraman, E.; Tyson, L.; Pizzo, B.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save